Regulatory Deadline Board/2026-14583
Centers for Medicare & Medicaid Services · Notice
Medicare Program; Inflation Reduction Act of 2022 (IRA) Medicare Drug Price Negotiation Program Draft Guidance; Comment Request
Closed 41 days ago
In plain English
CMS sought comment on draft guidance for how manufacturers effectuate the IRA Medicare Drug Price Negotiation maximum fair price in 2028.
Who it hits
Drug manufacturers in the negotiation program, PBMs, and Part D plans.
- Agency
- Centers for Medicare & Medicaid Services
- Document type
- Notice
- Published
- Jul 20, 2026
- Comments close
- Sep 18, 2026
- Status
- Closed 41 days ago
- Federal Register number
- 2026-14583
- Docket
- CMS-4219-N
More from Centers for Medicare & Medicaid Services
Proposed Rule · 47 days left
Medicare Program; Implementation of Sections 6219, 6220, and 6224 of the Consolidated Appropriations Act, 2026
Proposed Rule · 39 days left
Clinical Laboratory Improvement Amendments of 1988 (CLIA); Virtual Access, Gynecologic Cytology Proficiency Testing (PT), Personnel Qualifications, and Other Changes
Notice · 32 days left
Privacy Act of 1974; Matching Program
Proposed Rule · 25 days left
Request for Information; Medicare Part D Reasonable and Relevant Pharmacy Contracting Standards
Notice · 22 days left
Privacy Act of 1974; Matching Program
Notice · Closed 3 days ago
Privacy Act of 1974; Matching Program